• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯喹+周效磺胺-乙胺嘧啶、甲氟喹+青蒿琥酯以及蒿甲醚+本芴醇联合疗法治疗孟加拉国吉大港山区恶性疟原虫疟疾的疗效

Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.

作者信息

van den Broek I V, Maung U A, Peters A, Liem L, Kamal M, Rahman M, Rahman M R, Bangali A M, Das S, Barends M, Faiz A M

机构信息

MSF-UK, London, UK.

出版信息

Trans R Soc Trop Med Hyg. 2005 Oct;99(10):727-35. doi: 10.1016/j.trstmh.2005.02.007.

DOI:10.1016/j.trstmh.2005.02.007
PMID:16095643
Abstract

Bangladesh faces growing levels of Plasmodium falciparum resistance to chloroquine (CQ) and sulfadoxine-pyrimethamine (SP). Alternative antimalarial therapies, particularly combination regimens, need to be considered. Therefore, the efficacy of three antimalarial combination therapies was assessed in Chittagong Hill Tracts. A total of 364 P. falciparum patients were recruited and randomly assigned to either CQ + SP, mefloquine + artesunate (MQ + AS) or lumefantrine + artemether (Coartem). Results showed that CQ + SP therapy was less effective than the two artemisinin-based combination therapies. The day 42 PCR-corrected efficacy rate was 62.4% for CQ + SP, 100% for MQ + AS and 97.1% for Coartem. Failures occurred at a shorter interval after CQ + SP treatment than after Coartem. The artemisinin-based therapies effectively prevented development of gametocytes, whereas CQ + SP did not. All three therapies were well tolerated, although reports of mild complaints during treatment appeared higher with MQ + AS. We conclude that CQ + SP is not a viable option for replacing CQ monotherapy as first-line P. falciparum treatment in this area of Bangladesh. A change to artemisinin-based combination therapy is recommended. Both Coartem and MQ + AS appear to be good options, effective in curing P. falciparum malaria and in preventing recrudescences following treatment.

摘要

孟加拉国面临着恶性疟原虫对氯喹(CQ)和磺胺多辛-乙胺嘧啶(SP)耐药性不断增加的问题。需要考虑使用替代抗疟疗法,特别是联合用药方案。因此,在吉大港山区评估了三种抗疟联合疗法的疗效。总共招募了364名恶性疟原虫患者,并将他们随机分为接受CQ+SP、甲氟喹+青蒿琥酯(MQ+AS)或双氢青蒿素哌喹(科泰复)治疗。结果显示,CQ+SP疗法的效果不如两种以青蒿素为基础的联合疗法。CQ+SP疗法在第42天经PCR校正后的有效率为62.4%,MQ+AS为100%,科泰复为97.1%。CQ+SP治疗后出现失败的间隔时间比科泰复治疗后短。以青蒿素为基础的疗法能有效防止配子体的发育,而CQ+SP则不能。尽管在治疗期间,MQ+AS出现轻微不适的报告似乎较多,但所有三种疗法的耐受性都良好。我们得出结论,在孟加拉国的这一地区,CQ+SP不是替代CQ单药疗法作为一线恶性疟原虫治疗的可行选择。建议改用以青蒿素为基础的联合疗法。科泰复和MQ+AS似乎都是很好的选择,它们在治愈恶性疟原虫疟疾以及预防治疗后复发方面都很有效。

相似文献

1
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.氯喹+周效磺胺-乙胺嘧啶、甲氟喹+青蒿琥酯以及蒿甲醚+本芴醇联合疗法治疗孟加拉国吉大港山区恶性疟原虫疟疾的疗效
Trans R Soc Trop Med Hyg. 2005 Oct;99(10):727-35. doi: 10.1016/j.trstmh.2005.02.007.
2
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.在老挝人民民主共和国,氯喹加周效磺胺-乙胺嘧啶与青蒿琥酯加甲氟喹以及蒿甲醚-本芴醇治疗非复杂性恶性疟的随机对照研究
Clin Infect Dis. 2004 Oct 15;39(8):1139-47. doi: 10.1086/424512. Epub 2004 Sep 27.
3
Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.氯喹、周效磺胺/乙胺嘧啶、甲氟喹及甲氟喹-青蒿琥酯治疗缅甸北部克钦邦恶性疟的比较
Trop Med Int Health. 2004 Nov;9(11):1184-90. doi: 10.1111/j.1365-3156.2004.01323.x.
4
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.在布基纳法索,阿莫地喹联合磺胺多辛-乙胺嘧啶、蒿甲醚-本芴醇以及双氢青蒿素-哌喹治疗无并发症恶性疟原虫疟疾的随机对照研究
Clin Infect Dis. 2007 Dec 1;45(11):1453-61. doi: 10.1086/522985. Epub 2007 Oct 22.
5
Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola.氯喹、氨酚喹、周效磺胺-乙胺嘧啶以及氨酚喹+青蒿琥酯和周效磺胺-乙胺嘧啶+青蒿琥酯组合在安哥拉中部万博省和比耶省的抗疟疗效。
Trans R Soc Trop Med Hyg. 2005 Jul;99(7):485-92. doi: 10.1016/j.trstmh.2004.11.010.
6
Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.青蒿琥酯联合阿莫地喹与氯喹、阿莫地喹或磺胺多辛-乙胺嘧啶单药治疗阿富汗非复杂性恶性疟原虫感染的疗效比较。
Trop Med Int Health. 2005 Jun;10(6):521-9. doi: 10.1111/j.1365-3156.2005.01429.x.
7
Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations.苏丹努巴山区的疟疾:青蒿琥酯加磺胺多辛-乙胺嘧啶以及青蒿琥酯加阿莫地喹联合用药的基线基因型耐药性和疗效
Trans R Soc Trop Med Hyg. 2005 Jul;99(7):548-54. doi: 10.1016/j.trstmh.2004.10.003.
8
Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.在恶性疟原虫和间日疟原虫共同流行地区,磺胺多辛-乙胺嘧啶联合青蒿琥酯与氯喹治疗间日疟的疗效比较:阿富汗东部的一项随机非劣效性试验
Trans R Soc Trop Med Hyg. 2007 Nov;101(11):1081-7. doi: 10.1016/j.trstmh.2007.06.015. Epub 2007 Aug 17.
9
Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.青蒿琥酯加阿莫地喹、青蒿琥酯加磺胺多辛-乙胺嘧啶以及氯喹加磺胺多辛-乙胺嘧啶在科摩罗联盟非复杂性恶性疟患者中的疗效。
Acta Trop. 2007 Jun;102(3):176-81. doi: 10.1016/j.actatropica.2007.03.004. Epub 2007 May 3.
10
Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.氯喹、周效磺胺-乙胺嘧啶和甲氟喹治疗秘鲁北海岸非复杂性恶性疟的疗效
Am J Trop Med Hyg. 2003 Jan;68(1):120-3.

引用本文的文献

1
Examining the implementation of facility-based integrated management of childhood illness and insecticide treated nets in Bangladesh: lessons learned through implementation research.考察孟加拉国基于机构的儿童疾病综合管理和经杀虫剂处理的蚊帐的实施情况:通过实施研究获得的经验教训。
BMC Pediatr. 2024 Feb 28;23(Suppl 1):653. doi: 10.1186/s12887-023-04389-0.
2
Epidemiology of malaria in Rohingya refugee camps in Bangladesh within 2017-2020.2017-2020 年孟加拉国罗兴亚难民营疟疾流行病学。
Malar J. 2023 Sep 28;22(1):288. doi: 10.1186/s12936-023-04688-y.
3
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data.
急性无并发症恶性疟原虫疟疾的血液学后果:全球抗疟网个体化患者数据分析的 pooled 分析。
BMC Med. 2022 Mar 7;20(1):85. doi: 10.1186/s12916-022-02265-9.
4
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.《恶性疟原虫疟疾后间日疟原虫寄生虫血症风险:来自世界疟疾抗药性网络的个体患者数据荟萃分析》。
PLoS Med. 2020 Nov 19;17(11):e1003393. doi: 10.1371/journal.pmed.1003393. eCollection 2020 Nov.
5
The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis.蒿甲醚-本芴醇与非青蒿素类抗疟药对恶性疟原虫配子体携带及传播的相对影响:一项系统评价和荟萃分析
Clin Infect Dis. 2017 Aug 1;65(3):486-494. doi: 10.1093/cid/cix336.
6
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.恶性疟原虫疟疾治疗中耐药性的风险——一项系统评价和荟萃分析
Parasitol Res. 2017 Feb;116(2):781-788. doi: 10.1007/s00436-016-5353-2. Epub 2016 Dec 27.
7
G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study.葡萄糖-6-磷酸脱氢酶缺乏症与孟加拉国非重症疟疾的抗疟疗效:一项前瞻性观察研究
PLoS One. 2016 Apr 29;11(4):e0154015. doi: 10.1371/journal.pone.0154015. eCollection 2016.
8
A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission.蒿甲醚-本芴醇对配子体携带及疾病传播影响的综述。
Malar J. 2014 Jul 28;13:291. doi: 10.1186/1475-2875-13-291.
9
The story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study.青蒿琥酯-甲氟喹(ASMQ)的故事,药物研发中的创新伙伴关系:案例研究。
Malar J. 2013 Feb 21;12:68. doi: 10.1186/1475-2875-12-68.
10
Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies.缅甸三国交界地区临床和亚临床人群中耐药恶性疟原虫的分子监测:耐药性研究的横断面数据和系统评价。
Malar J. 2012 Sep 19;11:333. doi: 10.1186/1475-2875-11-333.